| What are the treatment options for cancer in Barrett's esophagus? |
| Block MI. Transthoracic vs.
transhiatal esophagectomy: Stage migration muddies the water. Journall
of Surgical Oncology 2006; 93(7): 519-20. |
|
Cameron AJ. Management of Barrett's esophagus. Mayo Clinic Proceedings 1998; 73(5):457-61. |
|
Chak A, Canto MI, Cooper GS, Isenberg G, Willis J, Levitan N, Clayman J, Forastiere A, Heath E, Sivak MVJ. Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients. Cancer 2000; 88(8):1788-95. |
| Christie NA, Patel AN,
Landreneau RJ. Esophageal palliation-photodynamic therapy/stents/brachytherapy.
Surgery Clinics of North America 2005;85(3):569-82. |
|
Collard JM, Romagnoli R, Hermans BP, Malaise J. Radical esophageal resection for adenocarcinoma arising in Barrett's esophagus. American Journal of Surgery 1997; 174(3):307-11. |
| Delgado Gomis F, Gomez
Abril SA, Martinez Abad M, Guallar Rovira JM. Assisted laparoscopic
transhiatal esophagectomy for the treatment of esophageal cancer.
Clinical Translational Oncology 2006; 8(3): 185-92. |
|
Ellis FHJ, Heatley GJ, Krasna MJ, Williamson WA, Balogh K. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. Journal of Thoracic and Cardiovascular Surgery 1997; 113(5):836-46; discussion 846-8.` |
|
Farrow DC, Vaughan TL. Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). Cancer Causes and Control 1996; 7(3):322-7. |
|
Fox JR, Kuwada SK. Today's approach to esophageal cancer. What is the role of the primary care physician? Postgraduate Medicine 2000; 107(5):109-14. |
| Geh JI, Bond SJ, Bentzen
SM, Glynne-Jones R. Systematic overview of preoperative (neoadjuvant)
chemoradiotherapy trials in oesophageal cancer: evidence of a
radiation and chemotherapy dose response. Radiotherapeutic Oncology
2006; 78(3):236-44. |
| Hammoud ZT, Kesler KA,
Ferguson MK, Battafarrano RJ, Bhogaraju A, Hanna N, Govindan R,
Mauer AA, Yu M, Einhorn LH. Survival outcomes of resected patients
who demonstrate a pathologic complete response after neoadjuvant
chemoradiation therapy for locally advanced esophageal cancer.
Diseases of the Esophagus 2006; 19(2):69-72. |
| Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer
J, Estes N, Haller DG, Ajani J, Kocha W, Minsky BD, Roth JA.
Chemotherapy followed by surgery compared with surgery alone for
localized esophageal cancer [see comments]. New England Journal of
Medicine 1998; 339(27):1979-84. |
| Khamly K, Jefford M,
Michael M, Zalcberg J. Recent developments in the systemic therapy
of advanced gastroesophageal malignancies. Expert Opinion In
Investigational Drugs 2006; 15(2):131-53. |
| Kozarek RA. Endoscopic
palliation of esophageal malignancy. Endoscopy 2003;35(8):S9-13. |
| Leonard GD, McCaffrey JA, and Maher M, Optimal therapy for
oesophageal cancer. Cancer Treatment Reviews, 2003. 29(4): p.
275-82. |
| Maunoury V, Mordon S,
Bulois P, Mirabel X, Hecquet B, Mariette C. Photodynamic therapy for
early esophageal cancer. Digestive Liver Diseases 2005; 37(7)491-5. |
|
Meyenberger C, Fantin AC. Esophageal carcinoma: current staging strategies. Recent Results in Cancer Research 2000; 155:63-72. |
| Minsky BD, Combined modality therapy for esophageal cancer. Seminars
in Oncology, 2003. 30(4 Suppl 9): p. 46-55. |
|
Minsky BD. Carcinoma of the esophagus. Part 1: Primary therapy. Oncology 1999; 13(9):1225-32, 1235-6. |
|
Minsky BD. Carcinoma of the esophagus. Part 2: Adjuvant therapy. Oncology 1999; 13(10):1415-27; discussion 1427 passim. |
| Munden RF, Macapinlac HA,
Erasmus JJ. Esophageal cancer: the role of integrated CT-PET in
initial staging and response assessment after preoperative therapy.
Journal of Thoracic Imaging 2006;21(2): 137-45. |
| Oyama T, Tomori A, Hotta
K, Morita S, Kominato K, Tanaka M, Miyata Y. Endoscopic submucosal
dissection of early esophageal cancer. Clinical Gastroenterology and
Hepatology 2005; 3(7 Suppl 1): S67-70. |
| Sabharwal T, Morales JP,
Irani FG, Adam A. CIRSE: Cardiovascular and Interventional
Radiological Society of Europe. Quality improvement guidelines for
placement of esophageal stents. Cardiovascular Interventional
Radiology 2005;28(3):284-8. |
| Shah MA, Schwartz GK.
Treatment of metastatic esophagus and gastric cancer. Seminars in
Oncology 2004;31(4):574-87. |
| Soetikno R, Kaltenbach T,
Yeh R, Gotoda T. Endoscopic mucosal resection for early cancers of
the upper gastrointestinal tract. Journal of Clinical Oncology 2005;
23(20): 4490-8. |
| van Meerten E, Muller K,
Tilanus HW, Siersema PD, Eijkenboom WM, van Dekken H, Tran TX, van
der Gaast A. Neoadjuvant concurrent chemoradiation with weekly
paclitaxel and carboplatin for patients with oesophageal cancer: a
phase II study. British Journal of Cancer 2006; 94(10):1389-94. |
|
van Sandick JW, van Lanschot JJ, ten Kate FJ, Offerhaus GJ, Fockens P, Tytgat GN, Obertop H. Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making. Cancer 2000; 88(11):2429-37. |
| Wright CD. Esophageal cancer surgery in 2005. Minerva Chir.
2005 60(6): 431-44. |
